• OPEN AN ACCOUNT
Indian Indices
Nifty
15,752.05 -28.20
(-0.18%)
Sensex
52,907.93 -111.01
( -0.21%)
Bank Nifty
33,539.45 114.35
( 0.34%)
Nifty IT
28,064.25 220.90
( 0.79%)
Global Indices
Nasdaq
11,127.85 99.11
(0.90%)
Dow Jones
31,097.26 321.83
(1.05%)
Hang Seng
21,859.79 -137.10
(-0.62%)
Nikkei 225
25,935.62 -457.42
(-1.73%)
Forex
USD-INR
78.81 0.07
(0.10%)
EUR-INR
82.25 -0.34
(-0.41%)
GBP-INR
95.25 -0.48
(-0.51%)
JPY-INR
0.58 0.01
(0.90%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
279.0106639
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
25.92
76664.25
EPS(TTM)
Face Value()
Div & Yield %
36.66
2
0
 

NCL Research & Financial Services Ltd
NCL Research and Financial Services standalone net profit rises 33.33% in the September 2021 quarter
Nov 15,2021
Net profit of NCL Research and Financial Services rose 33.33% to Rs 0.12 crore in the quarter ended September 2021 as against Rs 0.09 crore during the previous quarter ended September 2020. Sales declined 39.62% to Rs 0.32 crore in the quarter ended September 2021 as against Rs 0.53 crore during the previous quarter ended September 2020.

ParticularsQuarter Ended
 Sep. 2021Sep. 2020% Var.
Sales0.320.53 -40
OPM %59.3822.64 -
PBDT0.180.12 50
PBT0.160.12 33
NP0.120.09 33